Clinical trial
Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in…
NCT00326378 · Samsung Medical Center, Other · Completed
Key facts
| NCT number | NCT00326378 |
|---|---|
| Title | Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer |
| Official title | A Multinational, Multicenter, Phase III Open Randomized Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-small Cell Lung Cancer (CCheIN) |
| Lead sponsor | Samsung Medical Center, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | consolidation chemotherapy with Docetaxel plus cisplatin, CCRT arm without consolidation chemotherapy |
| Enrollment | 434 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2013 |
| Completion | May 1, 2015 |
| First posted | May 16, 2006 |
| Last update posted | Jun 8, 2015 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: